Tumor Necrosis Factor-α Gene Polymorphisms Are Associated with Severity of Acute Graft-Versus-Host Disease Following Matched Unrelated Donor Bone Marrow Transplantation in Children: A Pediatric Blood and Marrow Transplant Consortium Study

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 7, 2010, Pages

  Goyal, Rakesh K ^a,b   Lin, Yan ^c   Schultz, Kirk R ^d   Ferrell, Robert E ^c   Kim, Yeonhee ^c   Fairfull, Liane ^c   Livote, Elayne ^e   Yanik, Gregory ^f   Atlas, Mark ^g  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^f UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Graft versus host disease; Microsatellite; Pediatrics; Single nucleotide polymorphism; Tumor necrosis factor

Indexed keywords

ADENINE; BUSULFAN; CYCLOSPORIN; CYCLOSPORIN A; CYTOSINE; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1A; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CAUCASIAN; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PROSPECTIVE STUDY; PROTEIN FAMILY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77953615636     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.01.009     Document Type: Article

References (34)

1. Ferrara J.L., Levine J.E., Reddy P., et al. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
2. Hill G.R., Crawford J.M., Cooke K.R., et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997, 90:3204-3213.
3. Holler E., Kolb H.J., Hintermeier-Knabe R., et al. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant Proc 1993, 25:1234-1236.
4. Piguet P.F., Grau G.E., Allet B., et al. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med 1987, 166:1280-1289.
5. Busca A., Locatelli F., Marmont F., et al. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007, 82:45-52.
6. Levine J.E., Paczesny S., Mineishi S., et al. Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood 2008, 111:2470-2475.
7. Bogunia-Kubik K., Polak M., Lange A. TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 2003, 32:617-622.
8. Dickinson A.M., Harrold J.L., Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome?. Exp Rev Mol Med 2007, 9:1-19.
9. Hajeer A.H., Hutchinson I.V. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001, 62:1191-1199.
10. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
11. Sullivan K.M., Agura E., Anasetti C., et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991, 28:250-259.
12. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1140-1154.
13. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
14. Excoffier L., Slatkin M. Maximum likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12:921-927.
15. Hawley M.E., Kidd K.K. HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. J Hered 1995, 86:409-411.
16. Long J.C., Williams R.C., Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995, 56:799-810.
17. Attia J., Ioannidis J.P., Thakkinstian A., et al. How to use an article about genetic association, B: are the results of the study valid?. JAMA 2009, 301:191-197.
18. Bettens F., Passweg J., Gratwohl A., et al. Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic stem cell transplantation. Transplantation 2006, 81:1261-1267.
19. Cavet J., Middleton P.G., Segall M., et al. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999, 94:3941-3946.
20. Ishikawa Y., Kashiwase K., Akaza T., et al. Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 2002, 29:569-575.
21. Keen L.J., DeFor T.E., Bidwell J.L., et al. Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood 2004, 103:3599-3602.
22. Middleton P.G., Taylor P.R., Jackson G., et al. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998, 92:3943-3948.
23. Mullighan C., Heatley S., Doherty K., et al. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem cell transplantation. Transplantation 2004, 77:587-596.
24. Nordlander A., Uzunel M., Mattsson J., et al. The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation. Br J Haematol 2002, 119:1133-1136.
25. Rocha V., Franco R.F., Porcher R., et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002, 100:3908-3918.
26. Socie G., Loiseau P., Tamouza R., et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001, 72:699-706.
27. Takahashi H., Furukawa T., Hashimoto S., et al. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 2000, 26:1317-1323.
28. Lin M.T., Storer B., Martin P.J., et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003, 349:2201-2210.
29. Kogler G., Middleton P.G., Wilke M., et al. Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis. Transplantation 2002, 74:1167-1175.
30. Hanchard N., Diakite M., Koch O., et al. Implications of inter-population linkage disequilibrium patterns on the approach to a disease association study in the human MHC class III. Immunogenetics 2006, 58:465-470.
31. Valente F.P., Tan C.R., Temple S.E., et al. The evolution and diversity of TNF block haplotypes in European, Asian and Australian Aboriginal populations. Genes Immun 2009, 10:607-615.
32. Attia J., Ioannidis J.P., Thakkinstian A., et al. How to use an article about genetic association, A: background concepts. JAMA 2009, 301:74-81.
33. Stark G.L., Dickinson A.M., Jackson G.H., et al. Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation. Transplantation 2003, 76:1742-1749.
34. Puga I., Lainez B., Fernandez-Real J.M., et al. A polymorphism in the 3' untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression. Endocrinology 2005, 146:2210-2220.